GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » Capex-to-Operating-Income

Visioneering Technologies (ASX:VTI) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Visioneering Technologies's Capital Expenditure for the six months ended in Dec. 2023 was A$0.00 Mil. Its Operating Income for the six months ended in Dec. 2023 was A$-3.08 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Visioneering Technologies Capex-to-Operating-Income Historical Data

The historical data trend for Visioneering Technologies's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies Capex-to-Operating-Income Chart

Visioneering Technologies Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - - -

Visioneering Technologies Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Visioneering Technologies's Capex-to-Operating-Income

For the Medical Devices subindustry, Visioneering Technologies's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visioneering Technologies's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's Capex-to-Operating-Income falls into.



Visioneering Technologies Capex-to-Operating-Income Calculation

Visioneering Technologies's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -5.961
=N/A

Visioneering Technologies's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -3.079
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visioneering Technologies  (ASX:VTI) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Visioneering Technologies Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Visioneering Technologies (ASX:VTI) Business Description

Traded in Other Exchanges
N/A
Address
10745 Westside Way, Suite 200, Alpharetta, GA, USA, 30009
Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients.

Visioneering Technologies (ASX:VTI) Headlines

From GuruFocus

Top 5 4th Quarter Trades of Parisi Gray Wealth Management

By GuruFocus Research GuruFocus Editor 01-24-2023

Carl P. Sherr & Co., LLC Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-03-2023

MITCHELL MCLEOD PUGH & WILLIAMS INC's Top 5 Buys of the 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-18-2022

Top 5 4th Quarter Trades of Windham Capital Management, LLC

By GuruFocus Research GuruFocus Editor 02-10-2023

Top 5 3rd Quarter Trades of NISA INVESTMENT ADVISORS, LLC

By GuruFocus Research GuruFocus Editor 11-07-2022

AGILIS PARTNERS LLC Buys 1, Sells 4 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-07-2023

Top 5 4th Quarter Trades of Foster Group, Inc.

By GuruFocus Research GuruFocus Editor 01-24-2023

Top 5 3rd Quarter Trades of VISTA CAPITAL PARTNERS, INC.

By GuruFocus Research GuruFocus Editor 11-08-2022

D'Orazio & Associates, Inc. Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 01-26-2023

Top 5 4th Quarter Trades of OPPENHEIMER ASSET MANAGEMENT INC.

By GuruFocus Research GuruFocus Editor 02-07-2023